Market Analysis
The global Adipose Tissue-derived Stem Cell
Therapy market was valued at US$ 578.9 million in 2024 and is projected to grow to US$ 1.01 billion by 2030, reflecting a CAGR of 9.8% during the forecast period (2024–2030).
This substantial growth is attributed to expanding clinical applications, increased research funding, and greater acceptance of regenerative therapies worldwide.
Competitor Analysis
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
